Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

309
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
309
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

207
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
207
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

230
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
230
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

1.7K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.7K
Cross-reactivity00:42

Cross-reactivity

33.2K
Overview
33.2K
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

1.8K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative sedimentation equilibrium analysis of two IgG1 glycoforms: IgGCri and IgGWid.

European biophysics journal : EBJ·2023
Same author

Enhanced Immunomodulatory Effect of Intravenous Immunoglobulin by Fc Galactosylation and Nonfucosylation.

Frontiers in immunology·2022
Same author

Micro-Heterogeneity of Antibody Molecules.

Experientia supplementum (2012)·2021
Same author

Importance and Monitoring of Therapeutic Immunoglobulin G Glycosylation.

Experientia supplementum (2012)·2021
Same author

Lymphoma Driver Mutations in the Pathogenic Evolution of an Iconic Human Autoantibody.

Cell·2020
Same author

Structural Determination of the Broadly Reactive Anti-IGHV1-69 Anti-idiotypic Antibody G6 and Its Idiotope.

Cell reports·2017

Related Experiment Video

Updated: Feb 25, 2026

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

19.3K

Biologics: structural heterogeneity and immunogenicity.

Roy Jefferis1

  • 1Emeritus Professor, Institute of Immunology and Immunotherapy, University of Birmingham College of Medical and Dental Sciences, Birmingham B15 2TT.

British Journal of Hospital Medicine (London, England : 2005)
|August 8, 2017
PubMed
Summary
This summary is machine-generated.

Recombinant biologics can be immunogenic due to structural differences from human proteins. Optimizing oligosaccharide structures in therapeutic proteins is crucial for efficacy and safety.

More Related Videos

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
09:43

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

2.5K
Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

5.5K

Related Experiment Videos

Last Updated: Feb 25, 2026

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

19.3K
Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
09:43

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

2.5K
Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

5.5K

Area of Science:

  • Biotechnology
  • Immunology
  • Glycobiology

Background:

  • The human proteome offers vast potential for developing biologic drugs.
  • Recombinant proteins produced in heterologous systems can elicit immune responses due to structural variations.
  • Oligosaccharide structures are critical for protein function and immunogenicity.

Purpose of the Study:

  • To highlight the importance of oligosaccharide structure in recombinant protein therapeutics.
  • To discuss the immunogenic potential of biologics produced in non-human cell lines.
  • To illustrate optimization strategies using erythropoietin and antibody examples.

Main Methods:

  • Analysis of oligosaccharide structures in recombinant glycoproteins.
  • Comparison of endogenous versus heterologously produced proteins.
  • Case studies of recombinant erythropoietin and antibody therapeutics.

Main Results:

  • Non-human oligosaccharide residues can increase the immunogenicity of biologics.
  • Specific glycosylation patterns are essential for therapeutic protein function.
  • Hamster and murine cell lines present unique glycosylation challenges.

Conclusions:

  • Careful control of oligosaccharide structure is vital for safe and effective biologic drug development.
  • Understanding and engineering glycosylation can mitigate immunogenicity risks.
  • Optimization of therapeutic glycoproteins requires attention to glycan structure and its impact on immune recognition.